NCT02529826

Brief Summary

Due to remarkable advances in cancer treatments, the investigators are witnessing a growing population of long-term survivors of childhood malignancies. However, fertility in adult life may be severely impaired by gonadotoxic therapies. Since prepubertal boys cannot produce spermatozoa, banking of testicular tissue prior to gonadotoxic treatment is a crucial step towards fertility preservation for this population. Several centers around the world are now cryopreserving testicular tissue for prepubertal boys in anticipation that future technologies will allow the utilization of the banked samples for fertility restoration. Testicular tissue cryopreservation has now emerged as the leading strategy for fertility preservation in prepubertal boys before gonadotoxic treatments. Fertility restoration can theoretically be obtained after allo-transplantation of testicular tissue fragments that preserve both the SSCs and the supporting microenvironment (spermatogonial stem-cell niche).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 19, 2015

Completed
4 months until next milestone

First Posted

Study publicly available on registry

August 20, 2015

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2015

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2018

Completed
Last Updated

August 20, 2015

Status Verified

April 1, 2015

Enrollment Period

3 years

First QC Date

April 19, 2015

Last Update Submit

August 19, 2015

Conditions

Keywords

Cancer-affected prepubertal boys

Outcome Measures

Primary Outcomes (1)

  • Number of cancer affected prepubertal boys who will undergo testicular cryopreservation for fertility restoration.

    The investigators will report the number of cancer affected prepubertal boys that will undergo testicular cryopreservation for future fertility restoration.

    The time frame for this study is defined from the date of recruitment until the date of clinical utilization of the cryopreserved tissue for fertility restoration, up to forty years

Study Arms (1)

Testicular biopsy

EXPERIMENTAL

Cancer affected prepubertal boys will undergo testicular biopsy for testicular fragments cryopreservation. The biopsy will be performed by an attending urologist, before any gonadotoxic therapy is initiated. Testicular biopsy specimens will be divided immediately on the operating table. Two thirds of the specimen will be cryopreserved for potential use by the patient at a later date and will have the patient's details and will stay at the sperm bank of Hadassah Medical Center. The other third of specimen will be used for research purposes in an effort to advance the science of isolating and culturing human SSC's for fertility research.

Procedure: Testicular Biopsy

Interventions

An open testicular biopsy will be performed by an attending urologist under general anesthesia.

Testicular biopsy

Eligibility Criteria

Age3 Months - 18 Years
Sexmale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Prepubertal males newly diagnosed with high risk malignancy (not testicular), and whose treatment will include therapy with agents that place the boy at high risk for infertility are also eligible.

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hadassah Medical Organization

Jerusalem, Israel

Location

Related Publications (1)

  • Kabiri D, Safrai M, Gropp M, Hidas G, Mordechai-Daniel T, Meir K, Revel A, Imbar T, Reubinoff B. Establishment of a controlled slow freezing-based approach for experimental clinical cryopreservation of human prepubertal testicular tissues. F S Rep. 2021 Nov 5;3(1):47-56. doi: 10.1016/j.xfre.2021.11.001. eCollection 2022 Mar.

Study Officials

  • Doron Kabiri, MD

    Hadassah Hebrew Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 19, 2015

First Posted

August 20, 2015

Study Start

November 1, 2015

Primary Completion

November 1, 2018

Study Completion

November 1, 2018

Last Updated

August 20, 2015

Record last verified: 2015-04

Locations